| 000 | 01631 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250514031118.0 | ||
| 264 | 0 | _c20020430 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0007-0920 | ||
| 024 | 7 |
_a10.1038/sj.bjc.6600208 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMaring, J G | |
| 245 | 0 | 0 |
_aReduced 5-FU clearance in a patient with low DPD activity due to heterozygosity for a mutant allele of the DPYD gene. _h[electronic resource] |
| 260 |
_bBritish journal of cancer _cApr 2002 |
||
| 300 |
_a1028-33 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadverse effects |
| 650 | 0 | 4 | _aChromatography, High Pressure Liquid |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aDNA, Neoplasm _xgenetics |
| 650 | 0 | 4 | _aDihydrouracil Dehydrogenase (NADP) |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOxidoreductases _xgenetics |
| 650 | 0 | 4 | _aPoint Mutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aSequence Analysis, DNA |
| 700 | 1 | _avan Kuilenburg, A B P | |
| 700 | 1 | _aHaasjes, J | |
| 700 | 1 | _aPiersma, H | |
| 700 | 1 | _aGroen, H J M | |
| 700 | 1 | _aUges, D R A | |
| 700 | 1 | _aVan Gennip, A H | |
| 700 | 1 | _aDe Vries, E G E | |
| 773 | 0 |
_tBritish journal of cancer _gvol. 86 _gno. 7 _gp. 1028-33 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6600208 _zAvailable from publisher's website |
| 999 |
_c11856610 _d11856610 |
||